Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.4K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.1K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

657
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
657
Initiation of Translation02:33

Initiation of Translation

38.9K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.9K
Initiation of Translation02:33

Initiation of Translation

8.1K
8.1K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

612
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
612

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and analysis of a cantilever-based MEMS switch with dielectric thin film material coatings for enhanced electrostatic actuation.

Scientific reports·2026
Same author

Trends of severe human metapneumovirus infections in India.

BMC infectious diseases·2026
Same author

IoT-integrated rGO@Ti<sub>3</sub>C<sub>2</sub>T<sub><i>x</i></sub> MXene-based ammonia sensors: a DFT mechanistic insight for real-time monitoring.

Nanoscale·2026
Same author

Mercapto-methylimidazole molecular memristors for high-performance resistive switching and artificial synaptic emulation.

Nanoscale·2026
Same author

Interfacial Salt Engineering with Alkali and Ammonium Additives for Stable Pure-Blue Perovskite Light-Emitting Diodes and Micropatterned Displays.

ACS nano·2026
Same author

Clinical Outcomes of GLP-1 Receptor Agonist and SGLT2 Inhibitor Combination Therapy in Heart Failure: A Real-World Propensity-Matched TriNetX Analysis.

Biomedicines·2026

Related Experiment Video

Updated: Jan 29, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.5K

Widaplik: A Fixed-Dose Triple Combination for Initial Hypertension Therapy.

Mahnoor Niaz1, Rimsha Ahmad2, Saifullah Khan1

  • 1From the Department of Internal Medicine, MedStar Health, Georgetown University School of Medicine, Washington, DC.

Cardiology in Review
|January 28, 2026
PubMed
Summary

Widaplik, a new triple therapy pill, offers an effective initial treatment for hypertension. It simplifies blood pressure management, aiming to improve control rates and reduce cardiovascular risks.

Keywords:
Widaplikblood pressure therapyhypertension

More Related Videos

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

11.3K
X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

14.9K

Related Experiment Videos

Last Updated: Jan 29, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.5K
The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

11.3K
X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

14.9K

Area of Science:

  • Cardiology
  • Pharmacology
  • Hypertension Management

Background:

  • Hypertension is a major modifiable risk factor for cardiovascular disease globally.
  • Suboptimal blood pressure control persists despite available therapies.
  • Current guidelines advocate for early combination therapy in hypertension management.

Purpose of the Study:

  • To review the pharmacologic basis for low-dose triple therapy in hypertension.
  • To examine clinical trial evidence for a novel fixed-dose triple combination pill (telmisartan, amlodipine, indapamide).
  • To discuss the role of this new therapy in improving hypertension control and reducing cardiovascular risk.

Main Methods:

  • Review of pharmacologic rationale for complementary mechanisms of action.
  • Examination of pivotal Phase 3 clinical trial data.
  • Analysis of safety, tolerability, and practical considerations.

Main Results:

  • The triple therapy demonstrated rapid and sustained blood pressure reduction.
  • Higher hypertension control rates were observed compared to dual therapy.
  • Favorable tolerability profile was reported in clinical trials.

Conclusions:

  • Widaplik, a fixed-dose triple combination, is the first approved for initial hypertension treatment in patients likely needing multiple drugs.
  • This simplified approach targets key mechanisms for improved blood pressure control.
  • Further research is needed on long-term cardiovascular outcomes.